Rapid Micro Biosystems (RPID) Income from Continuing Operations (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Income from Continuing Operations of 14275000.0 for Q1 2026, down 14.23% sequentially from 12497000.0 in Q4 2025, and down 26.74% YoY from 19486041.09 in Q1 2025.
Rapid Micro Biosystems (RPID) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Income from Continuing Operations for 7 years, with the latest figure at 14275000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 26.74% year-over-year to 14275000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50135000.0 (down 11.83% YoY) and the FY2025 annual result came in at 47123000.0, changed 0.5% from the prior year.
- Income from Continuing Operations eased to 14275000.0 in Q1 2026 per RPID's latest filing, from 12497000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 9666000.0 in Q4 2024 and troughed at 16464000.0 in Q4 2022.
- A 5-year average of 13034705.88 and a median of 13103000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations soared 34.61% in 2022, then slipped 29.29% in 2025.
- Over 5 years, Income from Continuing Operations stood at 16464000.0 in 2022, then jumped by 32.14% to 11172000.0 in 2023, then rose by 13.48% to 9666000.0 in 2024, then slipped by 29.29% to 12497000.0 in 2025, then slipped by 14.23% to 14275000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 14275000.0, 12497000.0, and 11505000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Rapid Micro Biosystems | 81.71 Mn | 61.94 Mn | 1.21 Mn | -12.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.92 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | -12.50 Mn |
| Sep 30, 2025 | -11.51 Mn |
| Jun 30, 2025 | -11.86 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | -9.67 Mn |
| Sep 30, 2024 | -11.32 Mn |
| Jun 30, 2024 | -12.58 Mn |
| Mar 31, 2024 | -13.32 Mn |
| Dec 31, 2023 | -11.17 Mn |
| Sep 30, 2023 | -13.39 Mn |
| Jun 30, 2023 | -14.02 Mn |
| Mar 31, 2023 | -13.89 Mn |
| Dec 31, 2022 | -16.46 Mn |
| Sep 30, 2022 | -16.34 Mn |
| Jun 30, 2022 | -13.10 Mn |
| Mar 31, 2022 | -14.93 Mn |
| Dec 31, 2021 | -14.61 Mn |
| Sep 30, 2021 | -24.99 Mn |